Rechercher des projets européens

23 projets européens trouvés

Recherche sur 125080 projets européens

 EN COURS 
Colorectal cancer (CRC) is the 3rd most common cancer in Europe, and with approximately 200,000 deaths per year, it remains the 2nd most common cause of cancer death. More than half of all CRC patients develop distant metastases and have 5-year overall survival (OS) of less than 5% because of ineffective treatments. Increased understanding of cancer biology, coupled with the implementation of “omi ...
Voir le projet

 13

 EN COURS 

Evidence-based ICT tools for weight loss maintenance (NoHoW)

Date du début: 1 mars 2015, Date de fin: 29 févr. 2020,

Most adults who try to lose weight fail to maintain it. Obesity is a key economic and healthcare challenge for Europe. Effective interventions and commercial programmes for weight loss are widely available, but most people re-gain their lost weight. Currently few comprehensive solutions exist to help Europeans manage weight loss maintenance (WLM).Current research suggests the most promising eviden ...
Voir le projet

 16

 TERMINÉ 

Novel Stromal Cell Therapy for Diabetic Kidney Disease (NEPHSTROM)

Date du début: 1 mai 2015, Date de fin: 30 avr. 2019,

Type 2 diabetes will affect >500 million adults by 2040 and its secondary complications will generate enormous socioeconomic costs - in particular, diabetic kidney disease (DKD), which is already the most common cause of chronic kidney disease. DKD is associated with greatly increased mortality and frequently progresses to end stage renal failure. Pharmacotherapy, dialysis and transplantation repr ...
Voir le projet

 12

 TERMINÉ 
"Immune system response is the most complex barrier to long-term success of tissue transplants/implants from allogeneic and bio-artificial sources. While newly developed tissue transplant procedures are not yet performed frequently enough for robust analysis of adverse immune responses in humans, corneal transplantation (CT) is a well-established allogeneic tissue transplant with >100,000 full- an ...
Voir le projet

 12

 TERMINÉ 
Osteoarthritis (OA) is an incurable disease that has evaded pharmacological interference, biologic therapy or surgical intervention to prevent disease progression. Currently, OA is designated the 11th highest contributor (of 291 diseases) of global disability. In the absence of effective treatment options, cellular therapies using mesenchymal stem/stromal cells (MSCs) have emerged as potential can ...
Voir le projet

 20

 TERMINÉ 
AUTOSTEM will develop closed, scaleable and automated systems for therapeutic cell manufacture. The project vision is a donor-to-patient system where all aspects of processing, from tissue harvest to patient delivery are fully closed and aseptic. The process will involve new methods of biological cell selection from marrow, fat or other tissues, bioreactors to achieve scale and media formulations ...
Voir le projet

 10

 TERMINÉ 
Concept and aim: 20 million fans attend top division football games each week and many more watch on TV. Our social innovation is to attract people to lifestyle change through the personal connection and loyalty to the club they support. Our aim is to use this social innovation to change physical activity and sedentary behaviour, specially targeting low-SES groups, and men as well as women. EuroFI ...
Voir le projet

 13

 TERMINÉ 
Survival rates after childhood cancer now reach nearly 80% in developed European countries as a result of more effective therapies and better supportive care, leading to a steady increase in the number of survivors in the population. However, the treatments that have improved survival are harsh and cause serious side-effects that can greatly impact survivors’ quality of life in the long term. The ...
Voir le projet

 19

 TERMINÉ 

The Novel Materials Discovery Laboratory (NoMaD)

Date du début: 1 nov. 2015, Date de fin: 31 oct. 2018,

Essentially every new commercial product, be they smart phones, solar cells, batteries, transport technology, artificial hips, etc., depends on improved or even novel materials. Computational materials science is increasingly influential as a method to identify such critical materials for both R&D. Enormous amounts of data, precious but heterogeneous and difficult to access or utilise, are already ...
Voir le projet

 11

 TERMINÉ 

MEsenchymal stem cells to Reduce Liver INflammation (MERLIN)

Date du début: 1 févr. 2014, Date de fin: 31 janv. 2018,

"Prevalence of liver disease is c6% (29 million people) in the EU with mortality rates from chronic liver diseases estimated at 14.3 per 100.000 in the EU-25 in 2004. Most liver diseases have a significant inflammatory component that underpins liver damage and fibrogenesis, yet current therapies have limited effectiveness. Safe novel anti-inflammatory therapies would satisfy a large unmet need for ...
Voir le projet

 9

 TERMINÉ 

Security System for language and image analysis (Slandail)

Date du début: 1 avr. 2014, Date de fin: 31 mars 2017,

Project Slándáil will demonstrate a cost-effective and ethically-correct way in which social media information can be used by an emergency management system. The social media landscape consists of a range of digitized documents in a variety of formats, updated by a diverse and geographically distributed people and organisations. During an emergency, authorities use websites and the population, emp ...
Voir le projet

 12

 TERMINÉ 

Repair of Diabetic Damage by Stromal Cell Administration (REDDSTAR)

Date du début: 1 nov. 2012, Date de fin: 31 oct. 2016,

50 million diabetic EU citizens are using approved anti-diabetic agents to control their glycaemia. However, suboptimal glycemic control leads to 6 progressive diabetic complications, namely: nephropathy, retinopathy, cardiomyopathy, neuropathy and foot ulceration. In 2010, 11% of EU adult deaths (634,000) were caused by diabetic complications. These distinct disorders have few effective medicines ...
Voir le projet

 10

 TERMINÉ 
In recent years the treatment paradigm for metastatic colorectal cancer (mCRC) has evolved in complexity to include newly developed targeted therapeutics. In 2004 bevacizumab (bvz) [Avastin] became the first anti-angiogenic drug to be licensed in malignant disease, based on the results of a randomised trial in advanced metastatic colorectal cancer. Nevertheless, over the past six year period emerg ...
Voir le projet

 12

 TERMINÉ 
"Type 2 diabetes (T2DM) is preventable by sustained changes in diet and physical exercise. Despite this, modern societies are already approaching 10% population prevalence of diabetes, and another 15% with pre-diabetes. The costs of T2DM are huge, approaching 10% of all health costs. Prevention of diabetes is a priority for national healthcare agencies and for the health insurance industry. Inve ...
Voir le projet

 12

 TERMINÉ 
"The overall aim of this project is to offer a deeper understanding of the different mechanisms involved in the management of chronic conditions with a specific focus on how initiatives are translated and embedded into the illness management practices in peoples’ everyday life. It is in work, domestic and community settings where these practices are shaped by the emotional, symbolic, ethical, eco ...
Voir le projet

 10

 TERMINÉ 

Innovative Midlife Intervention for Dementia deterrence (In-MINDD)

Date du début: 1 nov. 2012, Date de fin: 31 oct. 2015,

The European costs of dementia were estimated €177 billion and there is a growing gap between burden and budget. The debilitation associated with dementia makes it the most feared of conditions related to ageing .Modelling studies have estimated that if obesity rates dropped by 5%, dementia prevalence rates would be lower by 6% and a decline in physical inactivity rate by 5% would reduce dementia ...
Voir le projet

 5

 TERMINÉ 
This project is concerned with optimising the delivery of primary healthcare to European citizens who are migrants who experience language and cultural barriers in host countries. We focus on the implementation of evidence-based health information (e.g. guidelines to enhance communication in cross-cultural consultations) and interventions (e.g. training initiatives on interculturalism and the use ...
Voir le projet

 8

 TERMINÉ 

Apoptosis Modelling for Treatment Decisions in Colorectal Cancer (APO-DECIDE)

Date du début: 1 nov. 2012, Date de fin: 31 oct. 2014,

"With the arrival of new colorectal cancer (CRC) therapeutics targeting specific cell signalling pathways, such as anti-EGFR therapy, personalised cancer treatment is at the door step of clinical practise. This progress in drug development contrasts strikingly with current clinical practice, where decision making depends largely on clinical factors such as tumour staging and age of patient, with t ...
Voir le projet

 7

 TERMINÉ 

Glycomics by High-throughput Integrated Technologies (GlycoHIT)

Date du début: 1 janv. 2011, Date de fin: 30 juin 2014,

Protein glycosylation is a post-translational phenomenon that is involved in most physiological and disease processes including cancer. Most of the known cancer-associated glycobiomarkers were discovered individually using liquid chromatography and mass spectroscopy. Though valuable, there is room for improvement in these approaches for the discovery phase. There is also a critical need for innova ...
Voir le projet

 16

 TERMINÉ 

Robotics UBIquitous COgnitive Network (RUBICON)

Date du début: 1 avr. 2011, Date de fin: 31 mars 2014,

Description Self-learning robotic ecology RUBICON will create a self-learning robotic ecology, consisting of a network of sensors, effectors and mobile robot devices. Enabling robots to seamlessly operate as part of these ecologies is an important challenge for robotics R&D, in order to support ap ...
Voir le projet

 10

 TERMINÉ 

CULTivating Understanding and Research through Adaptivity (CULTURA)

Date du début: 1 févr. 2011, Date de fin: 31 janv. 2014,

Description CULTURA's innovative adaptive services and interactive environment will offer genuine user empowerment and unprecedented levels of engagement with digital cultural heritage collections and communitiesA key challenge facing curators and providers of digital cultural heritage is to instigate, increase and enhance engagement with ...
Voir le projet

 7

 TERMINÉ 
Linked Heritage has 3 main objectives: I) to contribute large quantities of new content to Europeana, from both the public and private sectors; II) to demonstrate enhancement of quality of content, in terms of metadata richness, re-use potential and uniqueness; III) to demonstrate enable improved search, retrieval and use of Europeana content.Linked Heritage will facilitate and deliver large-sca ...
Voir le projet

 38

 TERMINÉ 
Stem cells offer a promising avenue to therapy for a wide range of complaints. However, for this potential to be realized, a consistent and plentiful supply of well-characterised stem cells is essential. There has been relatively little progress in the development of new culture technologies for the large-scale manufacture of mesenchymal stem cells (MSCs). There is a strong possibility that this ...
Voir le projet

 7